Home / Posts Tagged "(MRNA.O)."

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Vaccines weaker than expected in multiple myeloma patients Coronavirus vaccines are known to be less

READ MORE

A study run by the National Institutes of Health showed on Wednesday that people who got Johnson & Johnson Inc’s (JNJ.N) COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc (PFE.N)/BioNTech SE or Moderna Inc (MRNA.O). The study, which is preliminary

READ MORE